{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:01:05Z","timestamp":1781053265919,"version":"3.54.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research & Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.virol.2026.110970","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:43:50Z","timestamp":1779752630000},"page":"110970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The rationale for universal use of a prophylactic Epstein-Barr virus vaccine"],"prefix":"10.1016","volume":"622","author":[{"given":"Madeline R.","family":"Meirhaeghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-4365","authenticated-orcid":false,"suffix":"Jr.","given":"Henry H.","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.110970_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.virol.2026.110970_bib2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization","volume":"74","author":"Anagnostopoulos","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.virol.2026.110970_bib3","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2026.110970_bib4","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.virol.2026.110970_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.10933","article-title":"Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction","volume":"48","author":"Balandraud","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.virol.2026.110970_bib6","first-page":"866","article-title":"Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis","volume":"27","author":"Balandraud","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.virol.2026.110970_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.02.005","article-title":"Progress, prospects, and problems in Epstein-Barr virus vaccine development","volume":"6","author":"Balfour","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2026.110970_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein\u2013Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110970_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41390-019-0591-5","article-title":"The promise of a prophylactic Epstein-Barr virus vaccine","volume":"87","author":"Balfour","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.virol.2026.110970_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virol.2026.110970_bib11","first-page":"1397","article-title":"Epstein\u2013Barr virus and Burkitt lymphoma","volume":"60","author":"Brady","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.virol.2026.110970_bib12","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.virol.2026.110970_bib13","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1182\/blood-2013-04-499004","article-title":"The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1","volume":"122","author":"Cader","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.virol.2026.110970_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2026.110970_bib15","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1128\/JVI.00430-08","article-title":"Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K\/Akt\/FOXO3a pathway in human epithelial cells","volume":"82","author":"Chen","year":"2008","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2026.110970_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5230\/jgc.2016.16.1.1","article-title":"Epstein-Barr virus-associated gastric carcinoma and specific features of the accompanying immune response","volume":"16","author":"Cho","year":"2016","journal-title":"J. Gastr. Cancer"},{"key":"10.1016\/j.virol.2026.110970_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-981-10-7230-7_22","article-title":"Vaccine development for Epstein-Barr virus","volume":"1045","author":"Cohen","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2026.110970_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14760584.2019.1605906","article-title":"Prophylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: emerging strategies for clinical development","volume":"18","author":"Dasari","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2026.110970_bib20","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.virol.2026.110970_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.virol.2026.110970_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/AHMT.S94170","article-title":"Burkitt lymphoma in adolescents and young adults: management challenges","volume":"8","author":"Dozzo","year":"2017","journal-title":"Adolesc. Health Med. Therapeut."},{"key":"10.1016\/j.virol.2026.110970_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104007","article-title":"EBV as the \u201cgluten of MS\u201d hypothesis provides a rationale for trialing antiviral therapies","volume":"64","author":"Drosu","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.virol.2026.110970_bib24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J. Virol."},{"issue":"7335","key":"10.1016\/j.virol.2026.110970_bib25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.110970_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.mi.27.100173.002213","article-title":"The EB virus","volume":"27","author":"Epstein","year":"1973","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.virol.2026.110970_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","article-title":"Epstein-Barr virus lytic infection promotes activation of toll-like receptor 8 innate immune response in systemic sclerosis monocytes","volume":"19","author":"Farina","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.virol.2026.110970_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651013","article-title":"Innate immune modulation induced by EBV lytic infection promotes endothelial cell inflammation and vascular injury in scleroderma","volume":"12","author":"Farina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110970_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010017","article-title":"Do epstein-barr virus mutations and natural genome sequence variations contribute to disease?","volume":"12","author":"Farrell","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.virol.2026.110970_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/blood-2006-11-059881","article-title":"Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells","volume":"111","author":"Flavell","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.virol.2026.110970_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semcancer.2011.12.002","article-title":"Role of EBNA1 in NPC tumourigenesis","volume":"22","author":"Frappier","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.virol.2026.110970_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/0277-5379(93)90009-T","article-title":"Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda","volume":"19","author":"Geser","year":"1983","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.virol.2026.110970_bib33","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","article-title":"Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule","volume":"16","author":"Gires","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2026.110970_bib34","first-page":"171","article-title":"First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen","volume":"84","author":"Gu","year":"1995","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.virol.2026.110970_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/2281053a0","article-title":"Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients","volume":"228","author":"Gunv\u00e9n","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.110970_bib36","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/ijc.24293","article-title":"Evaluation of non-viral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China","volume":"124","author":"Guo","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2026.110970_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virol.2026.110970_bib38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp-2020-325688","article-title":"Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis","volume":"92","author":"Hedstr\u00f6m","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.virol.2026.110970_bib39","first-page":"1147","article-title":"Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups","volume":"43","author":"Henle","year":"1969","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.virol.2026.110970_bib40","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/jb.91.3.1248-1256.1966","article-title":"Immunofluorescence in cells derived from Burkitt's lymphoma","volume":"91","author":"Henle","year":"1966","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.virol.2026.110970_bib41","first-page":"13","article-title":"High incidence of Epstein-Barr virus genomes in Hodgkin's disease","volume":"137","author":"Herbst","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2026.110970_bib42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cgh.2022.07.042","article-title":"Estimating the global burden of Epstein-Barr virus-associated gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Hirabayashi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.110970_bib43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin's lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110970_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.virol.2026.110970_bib45","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","article-title":"Epidemiology of stomach cancer","volume":"28","author":"Ilic","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virol.2026.110970_bib46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1126\/science.aay3037","article-title":"Autoimmunity provoked by foreign antigens","volume":"368","author":"Iversen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virol.2026.110970_bib47","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virol.2026.110970_bib48","first-page":"325","article-title":"Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage","volume":"95","author":"Jons","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.virol.2026.110970_bib49","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr virus provides a survival factor to Burkitt's lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2026.110970_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","article-title":"Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections","volume":"15","author":"Khan","year":"2025","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.virol.2026.110970_bib51","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.virol.2026.110970_bib52","first-page":"E5115","volume":"115","author":"Lam","year":"2018"},{"key":"10.1016\/j.virol.2026.110970_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.virol.2026.110970_bib54","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201628RR","article-title":"The immune escape mechanism of nasopharyngeal carcinoma","volume":"37","author":"Li","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.virol.2026.110970_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/10732748221099227","article-title":"Recent estimates and predictions of 5-year survival in patients with gastric cancer: a model-based period analysis","volume":"29","author":"Li","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.virol.2026.110970_bib57","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2","volume":"205","author":"L\u00fcnemann","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2026.110970_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2016.05.032","article-title":"EBV-LMP1 suppresses the DNA damage response through DNA-PK\/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma","volume":"380","author":"Lu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.virol.2026.110970_bib58","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/1756-185X.14440","article-title":"Detection of Epstein\u2013Barr virus in systemic sclerosis patients: a molecular and serological based study","volume":"25","author":"Machhua","year":"2022","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.virol.2026.110970_bib59","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/1097-0142(195709\/10)10:5<1045::AID-CNCR2820100527>3.0.CO;2-0","article-title":"Epidemiological evidence of the nature of Hodgkin's disease","volume":"10","author":"Macmahon","year":"1957","journal-title":"Cancer"},{"key":"10.1016\/j.virol.2026.110970_bib60","first-page":"1189","article-title":"Epidemiology of Hodgkin's disease","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2026.110970_bib61","article-title":"EBV in Hodgkin lymphoma","volume":"1","author":"Massini","year":"2009","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110970_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/apm.12078","article-title":"Epstein\u2013Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979\u20132009","volume":"122","author":"Mbulaiteye","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.virol.2026.110970_bib63","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood","volume":"6","author":"Moon","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.virol.2026.110970_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.virol.2026.110970_bib65","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","article-title":"Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults","volume":"25","author":"Moutschen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110970_bib66","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V77.5.1092.1092","article-title":"Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma","volume":"77","author":"Neri","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.virol.2026.110970_bib67","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3390\/cancers6042259","article-title":"Epstein-Barr virus in gastric carcinoma","volume":"6","author":"Nishikawa","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.virol.2026.110970_bib68","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.31557\/APJCP.2019.20.11.3505","article-title":"Nasopharyngeal carcinoma (NPC) risk factors: a systematic review and meta-analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in Asian region","volume":"20","author":"Okekpa","year":"2019","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"Suppl. 3","key":"10.1016\/j.virol.2026.110970_bib69","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1086\/524380","article-title":"Economics of cardiac adverse events after smallpox vaccination: lessons from the 2003 US Vaccination program","volume":"46","author":"Ortega-Sanchez","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110970_bib70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein\u2013Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110970_bib71","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1084\/jem.129.4.707","article-title":"Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence","volume":"129","author":"Pearson","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2026.110970_bib72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12105-012-0401-4","article-title":"Nonkeratinizing undifferentiated nasopharyngeal carcinoma","volume":"7","author":"Peterson","year":"2012","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.virol.2026.110970_bib73","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/TP.0b013e3181b9d918","article-title":"A phase I trial of Epstein-Barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation","volume":"88","author":"Rees","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.virol.2026.110970_bib74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","article-title":"Epstein-Barr virus (EBV)-positive sporadic Burkitt lymphoma: an age-related lymphoproliferative disorder?","volume":"39","author":"Satou","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.virol.2026.110970_bib75","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mayocp.2024.09.017","article-title":"Population-based incidence of infectious mononucleosis and related hospitalizations: 2010 through 2021","volume":"100","author":"Sauver","year":"2025","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.virol.2026.110970_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-026-10274-4","article-title":"Host control of persistent Epstein-Barr virus infection","author":"Schmidt","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.110970_bib77","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0074-7742(07)79017-7","article-title":"Gender issues in multiple sclerosis","volume":"79","author":"Schwendimann","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.virol.2026.110970_bib79","first-page":"116","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.virol.2026.110970_bib80","first-page":"769","article-title":"Epstein-Barr virus-associated gastric adenocarcinoma","volume":"140","author":"Shibata","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2026.110970_bib81","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jnnp-2018-320189","article-title":"Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis","volume":"90","author":"Simpson","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.virol.2026.110970_bib82","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110970_bib83","article-title":"The global, regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019","volume":"12","author":"Song","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2026.110970_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","article-title":"Increased antibody levels to stage-specific Epstein\u2013Barr virus antigens in systemic autoimmune diseases reveal a common pathology","volume":"79","author":"Sternb\u00e6k","year":"2019","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"10.1016\/j.virol.2026.110970_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1116143","article-title":"The role of Epstein\u2013Barr virus in nasopharyngeal carcinoma","volume":"14","author":"Su","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.110970_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.583463","article-title":"EBV-positive gastric cancer: current knowledge and future perspectives","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.virol.2026.110970_bib87","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.virol.2026.110970_bib88","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.virol.2026.110970_bib89","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2026.110970_bib90","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.virol.2026.110970_bib91","first-page":"1250","article-title":"Epstein-Barr virus in gastric carcinoma","volume":"143","author":"Tokunaga","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2026.110970_bib92","first-page":"35","article-title":"EBNA1 IgM-based discrimination between rheumatoid arthritis patients","volume":"8","author":"Trier","year":"2019","journal-title":"Syst. Lupus Erythemat. Patient. Health. Contr."},{"key":"10.1016\/j.virol.2026.110970_bib93","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110970_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ebiom.2018.12.041","article-title":"Epstein-Barr virus, malaria and endemic Burkitt lymphoma","volume":"39","author":"Velavan","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virol.2026.110970_bib95","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.virol.2026.110970_bib96","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41408-024-01138-z","article-title":"Global, regional, and national burden of Burkitt lymphoma from 1990 to 2021 and predictions to 2030: a systematic analysis for the global burden of disease study 2021","volume":"14","author":"Wang","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.virol.2026.110970_bib97","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110970_bib98","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virol.2026.110970_bib99","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2012.07.004","article-title":"Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983\u20132008: suggestion of a potential protective role of oestrogen","volume":"49","author":"Xie","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.virol.2026.110970_bib100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CJI.0000000000000316","article-title":"Positive status of Epstein-Barr virus as a biomarker for gastric cancer immunotherapy: a prospective observational study","volume":"43","author":"Xie","year":"2020","journal-title":"J. Immunother."},{"key":"10.1016\/j.virol.2026.110970_bib101","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2020.09.019","article-title":"Epstein-Barr virus-associated gastric cancer: a distinct subtype","volume":"495","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.virol.2026.110970_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ady0210","article-title":"Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus","volume":"17","author":"Younis","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2026.110970_bib103","doi-asserted-by":"crossref","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling","volume":"9","author":"Zhang","year":"2023","journal-title":"JMIR Publ. Health Surveill."},{"key":"10.1016\/j.virol.2026.110970_bib104","article-title":"Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20\u201354 years from 1990 to 2021","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:38:19Z","timestamp":1781051899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":102,"alternative-id":["S0042682226001856"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110970","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rationale for universal use of a prophylactic Epstein-Barr virus vaccine","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110970","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110970"}}